# Harm Reduction: Resources

## Overview

This section provides curated resources for further reading, research, and engagement on harm reduction policy. Resources are organized by type and topic, with annotations describing relevance and perspective.

---

## Key Reports and Publications

### Government Reports

| Title | Author/Agency | Year | Relevance |
|-------|--------------|------|-----------|
| *Evidence-Based Strategies for Preventing Opioid Overdose: What's Working in the United States* | CDC | 2022 | Comprehensive federal overview of naloxone, SSPs, and MAT effectiveness |
| *Harm Reduction Framework* | White House/ONDCP | 2021 | First presidential administration document formally endorsing harm reduction |
| *Community-Based Opioid Overdose Prevention Programs Providing Naloxone* | CDC MMWR | 2023 | Detailed data on community naloxone distribution programs |
| *Drug Consumption Rooms: An Overview of Provision and Evidence* | EMCDDA | 2023 | Definitive international review of supervised consumption evidence |
| *Syringe Services Programs: Summary of Evidence* | CDC | 2024 | Federal summary of SSP effectiveness data |
| *National Drug Control Strategy* | ONDCP | 2024 | Annual federal drug policy strategy document |
| *Medications for Opioid Use Disorder* | SAMHSA TIP 63 | 2021 | Clinical guidelines for MAT |
| *HIV Prevention Among People Who Inject Drugs* | WHO | 2020 | Global evidence review for syringe services and harm reduction |

### Academic Research: Landmark Studies

| Title | Authors/Journal | Year | Key Finding |
|-------|----------------|------|-------------|
| "Effectiveness of needle exchange programmes for prevention of HIV" | Aspinall et al., *Lancet* | 2014 | Meta-analysis confirming 50%+ HIV reduction from SSPs |
| "Impact of supervised injection facilities on drug-related overdose death" | Kennedy et al., *The Lancet* | 2022 | 26-35% reduction in overdose deaths near SCS |
| "Emergency Department-Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence" | D'Onofrio et al., *NEJM* | 2015 | 78% treatment engagement at 30 days with ED-initiated MAT |
| "Association Between US State Medical Cannabis Laws and Opioid Prescribing" | Bradford et al., *JAMA Internal Medicine* | 2018 | Relevant context for drug policy interaction effects |
| "Supervised injection facilities: what the evidence says" | Potier et al., *Drug and Alcohol Dependence* | 2014 | Comprehensive review finding no increase in drug use or crime |
| "Effectiveness of naloxone distribution to laypersons" | Walley et al., *BMJ* | 2013 | Community naloxone reduces overdose mortality 27-46% |
| "Mortality risk during and after opioid substitution treatment" | Sordo et al., *BMJ* | 2017 | MAT reduces mortality; risk increases upon treatment exit |
| "Rapid Implementation of Service Delivery Changes for Opioid Treatment Programs During COVID-19" | Jones et al., *Drug and Alcohol Dependence* | 2021 | COVID flexibilities for methadone were feasible and effective |
| "Fentanyl test strip use behavior" | Peiper et al., *International Journal of Drug Policy* | 2019 | 70-90% of people who test positive change behavior |

### Policy Research

| Title | Organization | Year | Focus |
|-------|-------------|------|-------|
| *Harm Reduction: Shifting the Paradigm* | Pew Charitable Trusts | 2022 | State-level policy analysis and recommendations |
| *Supervised Consumption Sites: The Case for Authorization in the United States* | Drug Policy Alliance | 2023 | Policy case for SCS with cost-benefit analysis |
| *The Economics of Syringe Exchange* | Brookings Institution | 2021 | Cost-effectiveness analysis of SSPs |
| *Fentanyl Test Strips: Legal Status and Public Health Impact* | Network for Public Health Law | 2024 | Legal analysis of FTS across states |
| *Medication-Assisted Treatment: An Overview and Policy Considerations* | Congressional Research Service | 2023 | MAT policy overview for legislators |
| *Federal Funding for Syringe Services Programs* | Brennan Center for Justice | 2022 | Analysis of federal SSP funding restrictions |

---

## Organizations

### National Harm Reduction Organizations

| Organization | Website | Mission |
|-------------|---------|---------|
| National Harm Reduction Coalition (NHRC) | harmreduction.org | Training, advocacy, capacity building for harm reduction nationwide |
| Drug Policy Alliance (DPA) | drugpolicy.org | Drug policy reform advocacy; harm reduction, decriminalization, legalization |
| North American Syringe Exchange Network (NASEN) | nasen.org | SSP directory, technical assistance, network building |
| Harm Reduction International (HRI) | hri.global | Global harm reduction advocacy and research |
| NEXT Distro | nextdistro.org | National mail-based syringe and harm reduction supply distribution |

### Treatment and Recovery Organizations

| Organization | Website | Relevance |
|-------------|---------|-----------|
| SAMHSA | samhsa.gov | Federal treatment and harm reduction funding; national helpline (1-800-662-4357) |
| American Society of Addiction Medicine (ASAM) | asam.org | Clinical standards for addiction treatment including MAT |
| National Alliance for Medication Assisted Recovery (NAMA-R) | methadone.org | Methadone patient advocacy and treatment access |
| Faces and Voices of Recovery | facesandvoicesofrecovery.org | Recovery advocacy; supports harm reduction as pathway to recovery |

### Research Centers

| Center | Institution | Focus |
|--------|------------|-------|
| Center for Drug Use and HIV/HCV Research (CDUHR) | NYU School of Global Public Health | Drug use epidemiology, harm reduction evaluation |
| Center for Opioid Epidemiology and Policy | NYU Langone Health | Overdose prevention research |
| Bloomberg American Health Initiative | Johns Hopkins Bloomberg School | Drug policy research including fentanyl test strips |
| Addictions, Drug & Alcohol Institute | University of Washington | SSP research, MAT evaluation |
| Drug Free Communities Support Program | SAMHSA | Community-level prevention (note: prevention-focused, not harm reduction per se) |
| HIV/AIDS Prevention Research Division | CDC | HIV prevention among PWID |

### Legal and Policy Organizations

| Organization | Website | Relevance |
|-------------|---------|-----------|
| Network for Public Health Law | networkforphl.org | Legal technical assistance for harm reduction programs; FTS legal analysis |
| LawAtlas | lawatlas.org | Searchable database of state harm reduction laws |
| Legislative Analysis and Public Policy Association (LAPPA) | legislativeanalysis.org | Drug policy legislative tracking and analysis |
| ACLU | aclu.org | Drug policy reform litigation and advocacy |
| Law Enforcement Action Partnership (LEAP) | lawenforcementactionpartnership.org | Law enforcement professionals supporting harm reduction |

### Family and Survivor Organizations

| Organization | Website | Focus |
|-------------|---------|-------|
| Moms United to End the War on Drugs | momsunited.net | Mothers advocating for drug policy reform |
| FED UP! Coalition | fedupcoalition.org | Families for rational drug policy |
| The Voices Project | voicesproject.org | Storytelling platform for people affected by drug policy |
| Shatterproof | shatterproof.org | Family-centered addiction advocacy (note: treatment-focused) |

---

## Data Sources

### Federal Data Systems

| Source | URL | Data Available |
|--------|-----|---------------|
| CDC WONDER | wonder.cdc.gov | Overdose death data by year, state, substance, demographics |
| SAMHSA NSDUH | samhsa.gov/data/nsduh | Annual household survey on substance use and mental health |
| SAMHSA N-SSATS | samhsa.gov/data/data-we-collect/n-ssats | Treatment facility survey data |
| SAMHSA OTP Directory | dpt2.samhsa.gov/treatment | Opioid Treatment Program (methadone clinic) locator |
| DEA ARCOS | deadiversion.usdoj.gov | Opioid distribution data |
| HCUP/AHRQ | hcup-us.ahrq.gov | Hospital and ED data on overdose-related visits |
| Census of Fatal Occupational Injuries | bls.gov | Workplace overdose data |

### State and Local Data

| Source | Coverage | Data Available |
|--------|----------|---------------|
| State vital statistics offices | State-level | Overdose death data, often with greater detail than CDC |
| State prescription drug monitoring programs (PDMPs) | 50 states + D.C. | Opioid prescribing patterns |
| NASEN SSP Directory | National | Location and service data for SSPs |
| OpioidSettlementTracker.com | National | Opioid settlement fund allocation tracking |

---

## Educational Resources

### Training Programs

| Program | Provider | Audience |
|---------|----------|----------|
| Naloxone training (online) | Get Naloxone Now (getnaloxonenow.org) | General public |
| Harm Reduction Basics | National Harm Reduction Coalition | Service providers, advocates |
| Motivational Interviewing | SAMHSA | Healthcare providers, social workers |
| Providers Clinical Support System (PCSS) | SAMHSA/ASAM | Healthcare providers prescribing MAT |
| Overdose Response Training | Local SSPs and health departments | Community members, peers |

### Documentaries and Media

| Title | Year | Format | Description |
|-------|------|--------|-------------|
| *The Anonymous People* | 2013 | Documentary | Recovery advocacy and stigma reduction |
| *The Business of Recovery* | 2015 | Documentary | Critical examination of addiction treatment industry |
| *Heroin(e)* | 2017 | Short documentary (Oscar-nominated) | Three women fighting the opioid crisis in Huntington, WV |
| *The Crime of the Century* | 2021 | HBO documentary | Pharmaceutical industry's role in opioid crisis |
| *How to Survive a Plague* | 2012 | Documentary | ACT UP and AIDS activism (contextual for harm reduction history) |
| *Dopesick* | 2021 | Hulu series | Dramatization of the opioid crisis origins |

### Essential Books

| Title | Author | Year | Description |
|-------|--------|------|-------------|
| *Undoing Drugs: The Untold Story of Harm Reduction* | Maia Szalavitz | 2021 | Comprehensive history of the harm reduction movement |
| *Drug Use for Grown-Ups* | Carl Hart | 2021 | Neuroscientist's argument for drug autonomy and harm reduction |
| *Dreamland* | Sam Quinones | 2015 | Investigation of the opioid crisis origins |
| *Empire of Pain* | Patrick Radden Keefe | 2021 | History of Purdue Pharma and the Sackler family |
| *The Fix* | Michael Massing | 1998 | History of U.S. drug policy and treatment politics |
| *Harm Reduction: Pragmatic Strategies for Managing High-Risk Behaviors* | G. Alan Marlatt et al. | 2012 | Academic textbook on harm reduction theory and practice |
| *Chasing the Scream* | Johann Hari | 2015 | History of drug prohibition and the war on drugs |

---

## Legal Resources

### Key Federal Statutes

| Statute | Citation | Relevance |
|---------|----------|-----------|
| Controlled Substances Act | 21 U.S.C. 801 et seq. | Framework for drug scheduling and prohibition |
| "Crack house" statute | 21 U.S.C. 856 | DOJ interprets to prohibit supervised consumption sites |
| Drug Paraphernalia Act | 21 U.S.C. 863 | Federal paraphernalia prohibitions |
| SUPPORT Act | P.L. 115-271 (2018) | Expanded MAT access, naloxone provisions |
| MATE Act (within Omnibus 2023) | P.L. 117-328 (2022) | Eliminated X-waiver for buprenorphine prescribing |
| Ryan Haight Act | 21 U.S.C. 829(e) | Restrictions on online prescribing of controlled substances |

### Key Court Cases

| Case | Citation | Significance |
|------|----------|--------------|
| *United States v. Safehouse* | 985 F.3d 225 (3d Cir. 2021) (en banc) | Third Circuit ruled SCS violates 21 U.S.C. 856 |
| *Canada (AG) v. PHS Community Services Society* | 2011 SCC 44 | Supreme Court of Canada upheld Insite; Canadian precedent |
| *People v. Bordowitz* | 155 Misc. 2d 128 (N.Y. Crim. Ct. 1991) | Necessity defense for syringe exchange |
| *Bearden v. Georgia* | 461 U.S. 660 (1983) | Cannot incarcerate for inability to pay; relevant to drug user rights |

---

## Helplines and Immediate Resources

| Resource | Contact | Service |
|----------|---------|---------|
| SAMHSA National Helpline | 1-800-662-4357 | Free referral and information for substance use disorders |
| 988 Suicide and Crisis Lifeline | 988 | Mental health and substance use crisis support |
| NASEN SSP Finder | nasen.org/directory | Locate nearest syringe services program |
| SAMHSA Treatment Locator | findtreatment.gov | Find MAT and treatment providers |
| Poison Control (overdose guidance) | 1-800-222-1222 | Poison and overdose emergency guidance |
| Get Naloxone Now | getnaloxonenow.org | Locate free naloxone in your area |
| Never Use Alone | neverusealone.com | Hotline for people using drugs alone (1-800-484-3731) |

---

## Document Navigation

| Previous | Next |
|----------|------|
| [Roadmap](08-roadmap.md) | [Actions](10-actions.md) |

**Section Navigation:**
[Overview](01-overview.md) | [Current State](02-current-state.md) | [History](03-history.md) | [Root Causes](04-root-causes.md) | [Stakeholders](05-stakeholders.md) | [Opposition](06-opposition.md) | [Solutions](07-solutions.md) | [Roadmap](08-roadmap.md) | [Resources](09-resources.md) | [Actions](10-actions.md) | [Legislation](11-legislation.md) | [Perspectives](12-perspectives.md)
